169 related articles for article (PubMed ID: 9514909)
1. Infrequent inactivation of DCC gene in replication error-positive colorectal cancers.
Yamamoto H; Itoh F; Kusano M; Yoshida Y; Hinoda Y; Imai K
Biochem Biophys Res Commun; 1998 Mar; 244(1):204-9. PubMed ID: 9514909
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathologic and carcinogenetic appraisal of DNA replication error in sporadic T3N0M0 stage colorectal cancer after curative resection.
Liang JT; Chang KJ; Chen JC; Lee CC; Cheng YM; Hsu HC; Chien CT; Wang SM
Hepatogastroenterology; 1999; 46(26):883-90. PubMed ID: 10370632
[TBL] [Abstract][Full Text] [Related]
3. Clinical significance of p53, K-ras and DCC gene alterations in the stage I-II colorectal cancers.
Akkiprik M; Ataizi-Celikel C; Düşünceli F; Sönmez O; Gulluoglu BM; Sav A; Ozer A
J Gastrointestin Liver Dis; 2007 Mar; 16(1):11-7. PubMed ID: 17410283
[TBL] [Abstract][Full Text] [Related]
4. Aberration of p53 and DCC in gastric and colorectal cancer.
Kataoka M; Okabayashi T; Johira H; Nakatani S; Nakashima A; Takeda A; Nishizaki M; Orita K; Tanaka N
Oncol Rep; 2000; 7(1):99-103. PubMed ID: 10601600
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of microsatellite alteration in colorectal cancer].
Mizunuma H; Takita K; Ooki S; Onda M; Ando Y; Yoshida T; Tsuchiya A; Abe R
Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():443-9. PubMed ID: 9589050
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the genetic pathways involved in the pathogenesis of three types of colorectal cancer.
Tomlinson I; Ilyas M; Johnson V; Davies A; Clark G; Talbot I; Bodmer W
J Pathol; 1998 Feb; 184(2):148-52. PubMed ID: 9602705
[TBL] [Abstract][Full Text] [Related]
7. RER and LOH association with sporadic colorectal cancer in Taiwanese patients.
Tsai MH; Yang YC; Chen KH; Jiang JK; Chou SJ; Chiang TC; Jan HS; Lou MA
Hepatogastroenterology; 2002; 49(45):672-7. PubMed ID: 12063967
[TBL] [Abstract][Full Text] [Related]
8. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
9. Homozygous deletions inactivate DCC, but not MADH4/DPC4/SMAD4, in a subset of pancreatic and biliary cancers.
Hilgers W; Song JJ; Haye M; Hruban RR; Kern SE; Fearon ER
Genes Chromosomes Cancer; 2000 Apr; 27(4):353-7. PubMed ID: 10719364
[TBL] [Abstract][Full Text] [Related]
10. Clinico-pathological features and p53 expression in left-sided sporadic colorectal cancers with and without microsatellite instability.
Ilyas M; Tomlinson IP; Novelli MR; Hanby A; Bodmer WF; Talbot IC
J Pathol; 1996 Aug; 179(4):370-5. PubMed ID: 8869282
[TBL] [Abstract][Full Text] [Related]
11. DCC genetic alterations and expression in endometrial carcinoma.
Ronnett BM; Burks RT; Cho KR; Hedrick L
Mod Pathol; 1997 Jan; 10(1):38-46. PubMed ID: 9021725
[TBL] [Abstract][Full Text] [Related]
12. DCC and SMAD4 alterations in human colorectal and pancreatic tumor dissemination.
Tarafa G; Villanueva A; Farré L; Rodríguez J; Musulén E; Reyes G; Seminago R; Olmedo E; Paules AB; Peinado MA; Bachs O; Capellá G
Oncogene; 2000 Jan; 19(4):546-55. PubMed ID: 10698524
[TBL] [Abstract][Full Text] [Related]
13. Genomic instability and alterations in Apc, Mcc and Dcc in Hong Kong patients with colorectal carcinoma.
Ko JM; Cheung MH; Kwan MW; Wong CM; Lau KW; Tang CM; Lung ML
Int J Cancer; 1999 Aug; 84(4):404-9. PubMed ID: 10404094
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients.
Kubo H; Miki C; Kusunoki M
Hepatogastroenterology; 2004; 51(55):114-7. PubMed ID: 15011843
[TBL] [Abstract][Full Text] [Related]
15. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway.
Woodford-Richens KL; Rowan AJ; Gorman P; Halford S; Bicknell DC; Wasan HS; Roylance RR; Bodmer WF; Tomlinson IP
Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9719-23. PubMed ID: 11481457
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic pathway of sporadic colorectal cancer with novel germline missense mutations in the hMSH2 gene.
Yamada K; Zhong X; Kanazawa S; Koike J; Tsujita K; Hemmi H
Oncol Rep; 2003; 10(4):859-66. PubMed ID: 12792735
[TBL] [Abstract][Full Text] [Related]
17. Low expression of reduced folate carrier-1 and folylpolyglutamate synthase correlates with lack of a deleted in colorectal carcinoma mRNA splice variant in normal-appearing mucosa of colorectal carcinoma patients.
Wettergren Y; Odin E; Nilsson S; Willen R; Carlsson G; Gustavsson B
Cancer Detect Prev; 2005; 29(4):348-55. PubMed ID: 16122883
[TBL] [Abstract][Full Text] [Related]
18. Frequent loss of expression and loss of heterozygosity of the putative tumor suppressor gene DCC in prostatic carcinomas.
Gao X; Honn KV; Grignon D; Sakr W; Chen YQ
Cancer Res; 1993 Jun; 53(12):2723-7. PubMed ID: 8504411
[TBL] [Abstract][Full Text] [Related]
19. [p53 mutations in sporadic colorectal cancers with microsatellite instability].
Huang J; Zheng S; Pan QR; Deng YC
Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1130-3. PubMed ID: 12921629
[TBL] [Abstract][Full Text] [Related]
20. Genetic pathways of two types of gastric cancer.
Tahara E
IARC Sci Publ; 2004; (157):327-49. PubMed ID: 15055305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
